News

Axxam & InterMed Discovery Offer Integrated Screening Discovery Services from Natural Products for Flavor & Fragrance Industry Axxam and InterMed Discovery announced a three-year collaboration to provide complete screening solutions for the identification of bioactive compounds from natural sources to the flavor and fragrance industries. Axxam will provide assays and carry out the screening. InterMed […]

Axxam Announces Two Discovery Collaboration Agreements with Boehringer Ingelheim Axxam announced that the discovery research and services company has entered into two drug research collaboration agreements with Boehringer Ingelheim. The first collaboration agreement aims to identify and validate therapeutic targets with subsequent assay development, high-throughput screening (HTS) and lead optimization through the joint efforts of

Axxam Appoints Rose A. Lance to Lead Business Development in North America Axxam has appointed Rose A. Lance to lead the company’s business development efforts in North America. Based in Boston, MA in the United States, Ms. Lance will be responsible for marketing and promotion of discovery services and products for the rapidly-growing biotechnology company.

Axxam recognized as Young Innovative Company 2006 with Premio Unioncamere award The contribution of Axxam to Italian business was rewarded by Unioncamere, the organization uniting all of the Italian Chambers of Commerce, with the recent presentation in Rome of the prestigious Premio Unioncamere. Axxam received the Young Innovative Company award for 2006. The company was

Axxam Provides Screening Assays to NIH Chemical Genomics Centre for Collaboration on NIH Roadmap Initiative Axxam announced today that it has signed an agreement with the National Institutes of Health (NIH) to provide access to a selection of screening assays of special interest to the NIH Chemical Genomics Centre (NCGC) for use in the screening

Axxam Opens New Facility at Polaris Science and Technology Park (Cagliari) Axxam announced the opening of its new research facility at Polaris, the Scientific and Technological Park of Sardinia (Italy), a new centre of excellence for biotechnology. The new Axxam facility is located in the life science technologies centre in Pula (Cagliari) where pharmacology and

Axxam Appoints Suzanne Beveridge as Chief Corporate Communications Suzanne Beveridge has joined Axxam as Chief Corporate Communications, a newly-created position that will direct corporate communications strategy and manage public relations and marketing communications for the rapidly-growing biotechnology company. She has more than 20 years of career experience in life sciences. She builds on her strong

Axxam Appoints Luigi Gavazzeni as Chief Financial Officer Luigi Gavazzeni has been appointed Chief Financial Officer of Axxam. This newly-created position will be responsible for the financial management of the growing biotechnology company. His experience in the Italian biotechnology industry allows him to make considerable contribution to the strategic direction of the company. Prior to

Axxam Researchers Present at the 11th SBS Conference in Geneva, Switzerland At the 11th Society of Biomedical Screening (SBS) Conference, Geneva (Switzerland), Axxam scientists made podium presentations on the following topics: Electrogenic proteins: from cell based assay generation to HTS applications”, Sabrina Corazza Comprehensive Gene Expression Profiling of GPCRs and Ion Channels”, Paola Tarroni Axxam

Axxam Awarded FIT Grant for Novel Target Identification Axxam is pleased to announce the award of a grant from the Italian Ministero delle Attività; Produttive (MAP). The grant of €2.93 million will support a three year project in the field of novel target identification for pharmaceutical screening and recognizes the contribution of Axxam to Technological